Nitric oxide and the heart: Update on new paradigms

Annals of the New York Academy of Sciences

Volumn 1047, Issue , 2005, Pages 173-182

  Belge, C ^a   Massion, Paul B ^a   Pelat, M ^a   Balligand, J L ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Excitation contraction coupling; Inhibitors; NO; NOS

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADRENERGIC SYSTEM; CELL FUNCTION; CONFERENCE PAPER; EXCITATION CONTRACTION COUPLING; GENE DELETION; GENE OVEREXPRESSION; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE CELL; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION; VAGUS TONE;

EID: 23744489442     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1341.016     Document Type: Conference Paper

References (37)

1. MASSION, P.B., O. FERON, C. DESSY & J.L. BALLIGAND. 2003. Nitric oxide and cardiac function: ten years after, and continuing. Circ. Res. 93: 388-398.
2. FERON, O., L. BELHASSEN, L. KOBZIK, et al. 1996. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271: 22810-22814.
3. ELFERING, S.L., T.M. SARKELA & C. GIULIVI. 2002. Biochemistry of mitochondrial nitric-oxide synthase. J. Biol. Chem. 277: 38079-38086.
4. BALLIGAND, J.L., D. UNGUREANU, R.A. KELLY, et al. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91: 2314-2319.
5. BALLIGAND, J.L. 2002. Heat shock protein 90 in endothelial nitric oxide synthase signaling: following the lead(er)? Circ. Res. 90: 838-841.
6. FERON, O., C. DESSY, D.J. OPEL, et al. 1998. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J. Biol. Chem. 273: 30249-30254.
7. FLOGEL, U., M.W. MERX, A. GODECKE, et al. 2001. Myoglobin: a scavenger of bioactive NO. Proc. Natl. Acad. Sci. U.S.A. 98: 735-740.
8. GODECKE, A., A. MOLOJAVYI, J. HEGER, et al. 2003. Myoglobin protects the heart from inducible nitric-oxide synthase (iNOS)-mediated nitrosative stress. J. Biol. Chem. 278: 21761-21766.
9. DAMY, T., P. RATAJCZAK, E. ROBIDEL, et al. 2003. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J. 17: 1934-1936.
10. SEARS, C.E., E.A. ASHLEY & B. CASADEI. 2004. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359: 1021-1044.
11. MASSION, P.B. & J.L. BALLIGAND. 2003. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J. Physiol. 546: 63-75.
12. SEARS, C.E., S.M. BRYANT, E.A. ASHLEY, et al. 2003. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ. Res. 92: e52-e59.
13. BAROUCH, L.A., R.W. HARRISON, M.W. SKAF, et al. 2002. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416: 337-339.
14. KHAN, S.A., M.W. SKAF, R.W. HARRISON, et al. 2003. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ. Res. 92: 1322-1329.
15. BALLIGAND, J.L., R.A. KELLY, P. MARSDEN, et al. 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U.S.A. 90: 347-351.
16. GAUTHIER, C., V. LEBLAIS, L. Kobzik, et al. 1998. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest 102: 1377-1384.
17. CHENG, H.J., Z.S. ZHANG, K. ONISHI, et al. 2001. Upregulation of functional β(3)-adrenergic receptor in the failing canine myocardium. Circ. Res. 89: 599-606.
18. MORIMOTO, A., H. HASEGAWA, H.J. CHENG, et al. 2004. Endogenous β3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Am. J. Physiol. Heart. Circ. Physiol. 286: H2425-H2433.
19. MONIOTTE, S., L. KOBZIK, O. FERON, et al. 2001. Upregulation of β(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103: 1649-1655.
20. VARGHESE, P., R.W. HARRISON, R.A. LOFTHOUSE, et al. 2000. β(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. J. Clin. Invest. 106: 697-703.
21. ASHLEY, E.A., C.E. SEARS, S.M. BRYANT, et al. 2002. Cardiac nitric oxide synthase 1 regulates basal and β-adrenergic contractility in murine ventricular myocytes. Circulation 105: 3011-3016.
22. CHAMPION, H.C., D. GEORGAKOPOULOS, E. TAKIMOTO, et al. 2004. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circ. Res. 94: 657-663.
23. MASSION, P.B., C. DESSY, F. DESJARDINS, et al. 2004. Cardiomyocyte- restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates β-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110: 2666-2672.
24. HEGER, J., A. GODECKE, U. FLOGEL, et al. 2002. Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ. Res. 90: 93-99.
25. FUNAKOSHI, H.,T. KUBOTA, N. KAWAMURA, et al. 2002. Disruption of inducible nitric oxide synthase improves β-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ. Res. 90: 959-965.
26. PETROFF, M.G., S.H. KIM, S. PEPE, et al. 2001. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat. Cell Biol. 3: 867-873.
27. FERON, O., T.W. SMITH, T. Michel, R.A. Kelly. 1997. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J. Biol. Chem. 272: 17744-17748.
28. HERRING, N. & D.J. PATERSON. 2001. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J. Physiol. 535: 507-518.
29. MOHAN, R.M., D.A. HEATON, E.J. DANSON, et al. 2002. Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function. Circ. Res. 91: 1089-1091.
30. PATON, J.F., S. KASPAROV & D.J. PATERSON. 2002. Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci. 25: 626-631.
31. PIECH, A., P.E. MASSART, C. DESSY, et al. 2002. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am. J. Physiol. Heart. Circ. Physiol. 282: H219-H231.
32. PIECH, A., C. DESSY, X. HAVAUX, et al. 2003. Differential regulation of nitric oxide syntheses and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc. Res. 57: 456-467.
33. WUNDERLICH, C., U. FLOGEL, A. GODECKE, et al. 2003. Acute inhibition of myoglobin impairs contractility and energy state of iNOS-overexpressing hearts. Circ. Res. 92: 1352-1358.
34. PAULUS, W.J., S. FRANTZ & R.A. KELLY. 2001. Nitric oxide and cardiac contractility in human heart failure: time for reappraisal. Circulation 104: 2260-2262.
35. DAMY, T., P. RATAJCZAK, A.M. SHAH, et al. 2004. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363: 1365-1367.
36. TAKIMOTO, Y., T. AOYAMA, K. TANAKA, et al. 2002. Augmented expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats. Circulation 105: 490-496.
37. JANSSENS, S., P. POKREISZ, L. SCHOONJANS, et al. 2004. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ. Res. 94: 1256-1262.